Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2020

01-01-2020 | Editorial

Do Ulcers Heal Structurally and Functionally?

Author: Susan J. Hagen

Published in: Digestive Diseases and Sciences | Issue 1/2020

Login to get access

Excerpt

The gastric mucosa is constantly exposed to a harsh environment due to numerous factors, including abrasion from consumed food, damage from orally administered drugs, digestive factors produced by mucosal epithelial cells including gastric acid and pepsinogen, ischemia and other stressors, and infection with Helicobacter pylori. To meet these daunting challenges, the stomach has numerous mucosal defense mechanisms that prevent mucosal damage and maintain mucosal integrity [1]. Mucosal injury occurs when damaging factors overwhelm defensive factors or when mucosal defense mechanisms, per se, are impaired [1]. Gastric acid hypersecretion, the repeated ingestion of high salt-containing foods or nonsteroidal anti-inflammatory drugs (NSAIDs), and/or H. pylori infection can result in superficial injury or deep ulceration of the mucosa manifest as erosions or peptic ulcers that usually heal after the insult is removed. Despite the decreasing incidence of peptic ulcers in the past 20 years, largely attributed to the use of proton pump inhibitors to inhibit acid secretion and the eradication of H. pylori, peptic ulcers are still diagnosed in 5–10% of the general population [2, 3]. Furthermore, even after treatment for H. pylori infection, there is a cumulative 20% probability of ulcer recurrence within 6 months [4] with the 5-year cumulative probability of ulcer recurrence in the absence of H. pylori infection > 35% [5]. Despite active work to understand factors that facilitate the initiation of or protection against ulceration, mechanisms that regulate the recurrence (relapse) of previously healed ulcers are largely unknown. …
Literature
1.
go back to reference Laine L, Takeuchi K, Tarnawski AS. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008;135:41–60.CrossRef Laine L, Takeuchi K, Tarnawski AS. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008;135:41–60.CrossRef
2.
3.
go back to reference Everhart JE. The burden of digestive diseases in the United States. US Government Printing Office. 2008; NIH Publication No. 09-6443:97–106. Everhart JE. The burden of digestive diseases in the United States. US Government Printing Office. 2008; NIH Publication No. 09-6443:97–106.
4.
go back to reference Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol. 1998;93:1409–1415.PubMed Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol. 1998;93:1409–1415.PubMed
5.
go back to reference Seo JH, Hong SJ, Kim JH, et al. Long-term recurrence rates of peptic ulcers without Helicobacter pylori. Gut Liver. 2016;10:719–725.CrossRef Seo JH, Hong SJ, Kim JH, et al. Long-term recurrence rates of peptic ulcers without Helicobacter pylori. Gut Liver. 2016;10:719–725.CrossRef
6.
go back to reference Okabe S, Amagase K. An overview of acetic acid ulcer models—the history and state of the art of peptic ulcer research. Biol Pharm Bull. 2005;28:1321–1341.CrossRef Okabe S, Amagase K. An overview of acetic acid ulcer models—the history and state of the art of peptic ulcer research. Biol Pharm Bull. 2005;28:1321–1341.CrossRef
7.
go back to reference Aihara E, Matthis AL, Karns RA, et al. Epithelial regeneration after gastric mucosal ulceration causes prolonged cell-type alterations. Cell Mol Gastroenterol Hepatol. 2016;2:625–647.CrossRef Aihara E, Matthis AL, Karns RA, et al. Epithelial regeneration after gastric mucosal ulceration causes prolonged cell-type alterations. Cell Mol Gastroenterol Hepatol. 2016;2:625–647.CrossRef
9.
go back to reference Hagen SJ, Morrison SW, Law CS, Yang DX. Restitution of the bullfrog gastric mucosa is dependent on a DIDS-inhibitable pathway not related to HCO3 − ion transport. Am J Physiol Gastrointest Liver Physiol. 2004;286:G596–G605.CrossRef Hagen SJ, Morrison SW, Law CS, Yang DX. Restitution of the bullfrog gastric mucosa is dependent on a DIDS-inhibitable pathway not related to HCO3 ion transport. Am J Physiol Gastrointest Liver Physiol. 2004;286:G596–G605.CrossRef
10.
go back to reference Carothers JM, Forte JG, Machen TE. Computer modeling of the gastric parietal cell: significance of the canalicular space, gland lumen, and variable canalicular [K+]. Am J Physiol Gastrointest Liver Physiol. 2018;310:G671–G681.CrossRef Carothers JM, Forte JG, Machen TE. Computer modeling of the gastric parietal cell: significance of the canalicular space, gland lumen, and variable canalicular [K+]. Am J Physiol Gastrointest Liver Physiol. 2018;310:G671–G681.CrossRef
Metadata
Title
Do Ulcers Heal Structurally and Functionally?
Author
Susan J. Hagen
Publication date
01-01-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05935-6

Other articles of this Issue 1/2020

Digestive Diseases and Sciences 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.